Amrutha Menon

Dr. Amrutha Menon


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AMAmrutha Menon
Amrutha Menon
NANoraini Abd-Aziz
Noraini Abd-Aziz
KKKanwal Khalid
Kanwal Khalid
CPChit Laa Poh
Chit Laa Poh
RNRakesh Naidu
Rakesh Naidu
MicroRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cancer, they can act as a tumor suppressor or oncomiR depending on the cell type. Studies have shown that miRNA-based therapy, either by inhibiting an oncomiR or by inducing a tumor suppressor, is effective in cancer treatment. This review focusses on the role of miRNA in cancer, therapeutic approaches with miRNAs and how they can be effectively delivered into a system. We have also summarized the patents and clinical trials in progress for miRNA therapy.

18 October 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
JCJayesh Cherusseri
Jayesh Cherusseri
CSClaire Mary Savio
Claire Mary Savio
MKMohammad Khalid
Mohammad Khalid
VCVishal chaudhary
Vishal chaudhary
NANuman Arshid
Numan Arshid
Ajeet KaushikAjeet Kaushik
Ajeet Kaushik
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a “wicked evil” in this century due to its extended progression and huge human mortalities. Although the diagnosis of SARS-CoV-2 viral infection is made simple and practical by employing reverse transcription polymerase chain reaction (RT-PCR) investigation, the process is costly, complex, time-consuming, and requires experts for testing and the constraints of a laboratory. Therefore, these challenges have raised the paradigm of on-site portable biosensors on a single chip, which reduces human resources and enables remote access to minimize the overwhelming burden on the existing global healthcare sector. This article reviews the recent advancements in biosensors for long coronavirus disease (COVID) management using a multitude of devices, such as point-of-care biosensors and lab-on-chip biosensors. Furthermore, it details the shift in the paradigm of SARS-CoV-2-on-chip biosensors from the laboratory to on-site detection with intelligent and economical operation, representing near-future diagnostic technologies for public health emergency management.